CPIX (Cumberland Pharmaceuticals Inc) Stock Analysis - Hedge Fund Holdings
Cumberland Pharmaceuticals Inc (CPIX) is a publicly traded Healthcare sector company. As of May 21, 2026, CPIX trades at $5.47 with a market cap of $76.71M and a P/E ratio of -11.37. CPIX moved +0.00% today. Year to date, CPIX is +38.25%; over the trailing twelve months it is +9.94%. Its 52-week range spans $1.04 to $7.25. Rallies surfaces CPIX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns CPIX stock?
Hedge funds tracked by Rallies that own CPIX include Berkshire Asset. The latest tracked quarter is Mar 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Cumberland Pharmaceuticals Inc.
CPIX Key Metrics
Key financial metrics for CPIX
Metric
Value
Price
$5.47
Market Cap
$76.71M
P/E Ratio
-11.37
EPS
$-0.49
Dividend Yield
0.00%
52-Week High
$7.25
52-Week Low
$1.04
Volume
1.63K
Avg Volume
0
Revenue (TTM)
$41.94M
Net Income
$-7.40M
Gross Margin
82.89%
Top Hedge Funds Holding CPIX
Berkshire Asset holds 153.81K shares of CPIX, changed +0.00% as of Mar 31, 2025.
CPIX analyst coverage data. Average price target: $0.00.
Common questions about CPIX
Who owns CPIX stock?
Hedge funds tracked by Rallies that own CPIX include Berkshire Asset. The latest tracked quarter is Mar 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Cumberland Pharmaceuticals Inc.
Does Rallies show 13F holders for CPIX?
Yes. Rallies tracks hedge fund and 13F ownership data for CPIX, including fund names, share counts, latest tracked quarter, and position changes when available.
Is CPIX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CPIX. It does not provide personalized investment advice.
